50% off Premium Yearly

NYSE:DD
This summary was created by AI, based on 3 opinions in the last 12 months.
DuPont de Nemours Inc. has garnered a range of opinions from experts, particularly ahead of its upcoming earnings report. Notably, one expert highlights that the stock has experienced a parabolic rise, prompting them to sell some shares as a cautious approach to avoid greed. Despite this, the company's diverse business segments, particularly in water and materials, are praised for their robustness, and the CEO's leadership is acknowledged as commendable. A major point of interest is the anticipated split into two distinct entities—one focused on high-growth electronics and the other on stable sectors such as industrials, healthcare, and water. This strategic move is believed to enhance the overall value, with projections suggesting the stock could potentially reach $100 per share, which signifies a promising direction for DuPont.
This is in a tentative deal with Dow Chemical. DuPont was a bit of an MBA class analysis that was not run particularly well. Always a little bit of an underachiever. Nelson Peltz came, got some board seats and encouraged change. If they get together with Dow, we’ll see what comes out of it. He wouldn’t buy it at this point, simply because of the change that is going on, but he likes this scenario.